- Home
- AVDL vs PDO Comparison
AVDL vs PDO Comparison
Compare AVDL & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVDL | PDO |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVDL | PDO |
|---|---|---|
| Price | $21.51 | $13.99 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.38 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 520.0K |
| Earning Date | 03-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $248,517,000.00 | N/A |
| Revenue This Year | $65.47 | N/A |
| Revenue Next Year | $30.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.88 | N/A |
| 52 Week Low | $6.38 | $10.65 |
| 52 Week High | $23.57 | $13.31 |
Technical Indicators
Market Signals| Indicator | AVDL | PDO |
|---|---|---|
| Relative Strength Index (RSI) | 56.85 | 53.97 |
| Support Level | $21.45 | $13.94 |
| Resistance Level | $21.60 | $14.10 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 48.78 | 58.33 |
Price Performance
Historical ComparisonAbout AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.